Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology.

JCO precision oncology·2026
Same author

Impact of Radionecrosis and Local Recurrence on Overall Survival After Stereotactic Radiosurgery for Brain Metastases.

Advances in radiation oncology·2026
Same author

Another Round of MDT for MBC.

International journal of radiation oncology, biology, physics·2026
Same author

Outcomes of 5- Versus 10-Fraction Radiation Therapy for Hepatocellular Carcinoma at a Veteran Affairs Hospital.

International journal of radiation oncology, biology, physics·2026
Same author

The Optimization of Radiotherapy in Lung Cancer Treatment: 20 Years of Progress.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Toxicity of Ablative Radiation Therapy in the Management of Patients with Child-Pugh B/C Liver Function and Unresectable Hepatocellular Carcinoma (HCC).

Cancers·2026

Related Experiment Video

Updated: Apr 29, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K

Palliative radiotherapy for prostate cancer.

Matthew J Boyer, Joseph K Salama, W Robert Lee

    Oncology (Williston Park, N.Y.)
    |May 21, 2014
    PubMed
    Summary

    Palliative radiotherapy effectively manages prostate cancer symptoms, including painful bone metastases. Retreatment offers pain relief for about half of patients, while newer methods show promise for advanced disease.

    Area of Science:

    • Oncology
    • Radiation Oncology
    • Palliative Care

    Background:

    • Prostate cancer frequently metastasizes to bone, causing significant pain and morbidity.
    • Palliative radiotherapy is a cornerstone in managing cancer-related symptoms.
    • Effective symptom control improves quality of life for patients with advanced prostate cancer.

    Purpose of the Study:

    • To review the efficacy of palliative radiotherapy in managing prostate cancer symptoms.
    • To discuss various radiotherapy modalities and their roles in symptom palliation.
    • To highlight emerging techniques and their potential impact on patient outcomes.

    Main Methods:

    • Review of existing literature on palliative radiotherapy for prostate cancer.
    • Analysis of treatment outcomes for different radiation fractionation schedules.

    More Related Videos

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    1.1K
    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    13.4K

    Related Experiment Videos

    Last Updated: Apr 29, 2026

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
    08:34

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

    Published on: February 6, 2019

    20.6K
    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    1.1K
    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    13.4K
  • Evaluation of systemic and localized radiotherapy approaches.

    • Main Results:

    • External beam radiotherapy effectively palliates painful bone metastases, with similar efficacy for single or multiple fractions.
    • Approximately 50% of patients experience pain relief upon retreatment with radiation.
    • Systemic radiopharmaceuticals like radium-223 improve survival in castration-resistant prostate cancer and reduce pain from diffuse metastases.
    • Radiotherapy also improves hematuria, bladder outlet obstruction, and rectal compression symptoms.

    Conclusions:

    • Palliative radiotherapy is a versatile and effective treatment for various prostate cancer symptoms.
    • Different radiotherapy modalities offer tailored solutions for localized or diffuse metastatic disease.
    • Ongoing research, including stereotactic body radiation therapy, aims to further optimize pain management and outcomes.